iS Clinical Active Serum - 30g

Marsoni

M251S

$145.00

Get it in 3 business days with 1 day shipping. Friday, May 29

iS Clinical Active Serum - 30gOur most popular product, this fast acting, results orientated formula offers a multitude of benefits with long term results. This potent botanical serum generates a cool tingling sensation on application as it penetrates and works brilliantly by itself or as part of our specific regimes PRODUCT BENEFITS Skin hydration Antioxidant protection Skin brightening Improves circulation.

Easy Shipping

Quick Dispatch:

Your iS Clinical Active Serum - 30g orders ship within 1-2 business days.

Delivery Options:

Standard: 3-7 business days
Fast: 2-3 business days
Express: 1-2 business days

Order Tracking:

You'll receive a tracking link by email once your iS Clinical Active Serum - 30g ships.

Need Help?
Questions about iS Clinical Active Serum - 30g, sizing, or delivery? We're just an email away.

Live Shipping Estimates:
Enter your location at checkout to see available shipping methods and costs for iS Clinical Active Serum - 30g in your area.

Get Shipping Estimates

Country Zip/Postal Code

Exchange/Return Notes

We offer a 30-day return/exchange service after receiving.
Final sale items are not eligible for returns or exchanges.
To process your return/exchange, please contact us at [email protected]
Please click here for more details>>> Return & Exchange Policy

I love these sandals. They are well made, true to size and soft suede. They are lightweight and feel just like my UGG goldenstar sandals. (These are not as adjustable, so if you have narrow or wide feet, these may not be for you) These a great value for the money, especially for medium width feet. The strap across the toe is not adjustable, but fit my feet just fine. The ankle strap was a good length for me. And the Velcro is strong. These sandals are a great value for the money. I will probably start looking into kookaburra before I rush to buy the more expensive ones now.

WAS THIS REVIEW HELPFUL?YesReportShare

Reviewed in the United States on May 5, 2026